Stability and Solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular Perspective

AbstractPurpose. The purpose of the current study is to evaluate the solubility advantage offered by celecoxib (CEL) amorphous systems and to characterize and correlate the physical and thermodynamic properties of CEL and its amorphous molecular dispersions containing poly(vinylpyrrolidone) (PVP). Methods. The measurement of crystalline content, glass transition temperatures, and enthalpy relaxation was performed using differential scanning calorimetry. Solubility and dissolutions studies were conducted at 37°C to elucidate release mechanisms. Further, the amorphous systems were characterized by polarized light microscopy and X-ray powder diffraction studies. Results. The PVP content has a prominent effect on the stability and solubility profiles of amorphous systems. A dispersion of 20% w/w PVP with CEL resulted in a maxima in terms of solubility enhancement and lowering of relaxation enthalpy. The release of drug from amorphous molecular dispersions was found to be drug-dependent and independent of the carrier. Conclusions. The solubility enhancement and enthalpy relaxation studies with respect to PVP concentration helped in a better prediction of role of carrier and optimization of concentration in the use of solid dispersions or amorphous systems. The drug release mechanism is drug-controlled rather than carrier-controlled.

[1]  Bruno C. Hancock,et al.  Disordered drug delivery: destiny, dynamics and the Deborah number , 2002, The Journal of pharmacy and pharmacology.

[2]  P Augustijns,et al.  Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  G. Van den Mooter,et al.  Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. , 2002, International journal of pharmaceutics.

[4]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[5]  W. L. Chiou,et al.  PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSIONS , 1971 .

[6]  M. Suleiman,et al.  The Kinetics of Drug Release from Ethylcellulose Solid Dispersions , 1985 .

[7]  O. Corrigan.  Mechanisms of Dissolution of Fast Release Solid Dispersions , 1985 .

[8]  G. Alderborn,et al.  Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structure , 1994 .

[9]  A. Bansal,et al.  Characterization of solid-state forms of celecoxib. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  I. Kushida,et al.  Solid state characterization of E2101, a novel antispastic drug. , 2002, Journal of pharmaceutical sciences.

[11]  Bruno C. Hancock,et al.  Characteristics and Significance of the Amorphous State in Pharmaceutical Systems , 1997 .

[12]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[13]  G. Zografi,et al.  Mixing behavior of colyophilized binary systems. , 1998, Journal of pharmaceutical sciences.

[14]  W. Kob.  Supercooled Liquids and Glasses , 1999, cond-mat/9911023.

[15]  W. Higuchi,et al.  Investigation of factors influencing release of solid drug dispersed in inert matrices. 3. Quantitative studies involving the polyethylene plastic matrix. , 1966, Journal of pharmaceutical sciences.

[16]  A. Bansal,et al.  Enthalpy Relaxation Studies of Celecoxib Amorphous Mixtures , 2002, Pharmaceutical Research.

[17]  Bruno C. Hancock,et al.  The Relationship Between the Glass Transition Temperature and the Water Content of Amorphous Pharmaceutical Solids , 1994, Pharmaceutical Research.

[18]  Bruno C. Hancock,et al.  Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures , 1995, Pharmaceutical Research.

[19]  Paul F. McMillan,et al.  Polymorphic Phase Transitions in Liquids and Glasses , 1997, Science.

[20]  Bruno C. Hancock,et al.  Polyamorphism: a pharmaceutical science perspective , 2002, The Journal of pharmacy and pharmacology.

[21]  S. Riegelman,et al.  Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000. , 1970, Journal of pharmaceutical sciences.

[22]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[23]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.